SALIREPOSIDE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C20H22O9
Molecular Weight	406.3833
Optical Activity	UNSPECIFIED
Defined Stereocenters	5 / 5
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OC[C@H]1O[C@@H](OC2=CC=C(O)C=C2COC(=O)C3=CC=CC=C3)[C@H](O)[C@@H](O)[C@@H]1O

InChI

InChIKey=UQCOPGRRWQCCFR-BFMVXSJESA-N

InChI=1S/C20H22O9/c21-9-15-16(23)17(24)18(25)20(29-15)28-14-7-6-13(22)8-12(14)10-27-19(26)11-4-2-1-3-5-11/h1-8,15-18,20-25H,9-10H2/t15-,16-,17+,18-,20-/m1/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

.BETA.-D-GLUCOPYRANOSIDE, 2-((BENZOYLOXY)METHYL)-4-HYDROXYPHENYL

Preferred Name

English

SALIREPOSIDE

Common Name

English

Code System Code Type Description

CAS

16955-55-8

Created by admin on Mon Mar 31 22:55:14 GMT 2025 , Edited by admin on Mon Mar 31 22:55:14 GMT 2025

PRIMARY

PUBCHEM

117440

Created by admin on Mon Mar 31 22:55:14 GMT 2025 , Edited by admin on Mon Mar 31 22:55:14 GMT 2025

PRIMARY

FDA UNII

YUB3J70275

Created by admin on Mon Mar 31 22:55:14 GMT 2025 , Edited by admin on Mon Mar 31 22:55:14 GMT 2025

PRIMARY

EPA CompTox

DTXSID60937646

Created by admin on Mon Mar 31 22:55:14 GMT 2025 , Edited by admin on Mon Mar 31 22:55:14 GMT 2025

PRIMARY

SUBSTANCE RECORD


					YUB3J70275

SALIREPOSIDE